AstraZeneca Pharma India Limited financial reports, AstraZeneca Pharma India Limited annual revenue in 2024. When does AstraZeneca Pharma India Limited report revenue?
AstraZeneca Pharma India Limited total revenue, net income and dynamics of changes in Indian rupee today
Net revenue of AstraZeneca Pharma India Limited on 30/06/2020 amounted to 1 935 776 000 Rs. The dynamics of net revenue of AstraZeneca Pharma India Limited decreased. The change amounted to -13 252 000 Rs. The dynamics of net revenue is shown in comparison with the previous report. Net income AstraZeneca Pharma India Limited - 186 347 000 Rs. Information about net income is used from open sources. AstraZeneca Pharma India Limited online financial report chart. The financial schedule of AstraZeneca Pharma India Limited consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The value of "net income" AstraZeneca Pharma India Limited on the graph is displayed in blue.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2020
1 935 776 000 Rs
-5.369 % ↓
186 347 000 Rs
-13.389 % ↓
31/03/2020
1 949 028 000 Rs
+2.42 % ↑
95 777 000 Rs
-2.6013 % ↓
31/12/2019
2 238 628 000 Rs
-
267 017 000 Rs
-
30/09/2019
2 084 831 000 Rs
-
144 153 000 Rs
-
30/06/2019
2 045 613 000 Rs
-
215 154 000 Rs
-
31/03/2019
1 902 984 000 Rs
-
98 335 000 Rs
-
Show:
to
AstraZeneca Pharma India Limited financial report charts
Dates of AstraZeneca Pharma India Limited finance reports: 31/03/2019, 31/03/2020, 30/06/2020. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of AstraZeneca Pharma India Limited is 30/06/2020. Gross profit AstraZeneca Pharma India Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit AstraZeneca Pharma India Limited is 1 210 198 000 Rs
AstraZeneca Pharma India Limited quarterly report dates
Cost of revenue AstraZeneca Pharma India Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue AstraZeneca Pharma India Limited is 725 578 000 Rs Total revenue AstraZeneca Pharma India Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue AstraZeneca Pharma India Limited is 1 935 776 000 Rs Operating income AstraZeneca Pharma India Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income AstraZeneca Pharma India Limited is 240 103 000 Rs
Net income AstraZeneca Pharma India Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income AstraZeneca Pharma India Limited is 186 347 000 Rs
30/06/2020
31/03/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 210 198 000 Rs
1 087 746 000 Rs
1 425 452 000 Rs
1 343 283 000 Rs
1 345 222 000 Rs
1 234 844 000 Rs
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
725 578 000 Rs
861 282 000 Rs
813 176 000 Rs
741 548 000 Rs
700 391 000 Rs
668 140 000 Rs
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 935 776 000 Rs
1 949 028 000 Rs
2 238 628 000 Rs
2 084 831 000 Rs
2 045 613 000 Rs
1 902 984 000 Rs
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
2 238 628 000 Rs
2 084 831 000 Rs
2 045 613 000 Rs
1 902 984 000 Rs
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
240 103 000 Rs
107 134 000 Rs
319 924 000 Rs
289 190 000 Rs
309 353 000 Rs
26 529 000 Rs
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
186 347 000 Rs
95 777 000 Rs
267 017 000 Rs
144 153 000 Rs
215 154 000 Rs
98 335 000 Rs
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
1 695 673 000 Rs
1 841 894 000 Rs
1 918 704 000 Rs
1 795 641 000 Rs
1 736 260 000 Rs
1 876 455 000 Rs
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
-
5 423 200 000 Rs
-
4 845 389 000 Rs
-
4 047 200 000 Rs
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
-
7 063 600 000 Rs
-
6 461 019 000 Rs
-
5 618 000 000 Rs
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
-
835 000 000 Rs
-
2 311 849 000 Rs
-
1 732 400 000 Rs
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
2 994 513 000 Rs
-
2 589 800 000 Rs
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
3 165 192 000 Rs
-
2 610 000 000 Rs
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
48.99 %
-
46.46 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
3 644 400 000 Rs
3 644 400 000 Rs
3 295 827 000 Rs
3 295 827 000 Rs
3 008 000 000 Rs
3 008 000 000 Rs
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-
-
Last revenue report of AstraZeneca Pharma India Limited was 30/06/2020. According to last financial report total revenue in AstraZeneca Pharma India Limited was 1 935 776 000 Indian rupee and changed by -5.369% since last year. Net income in AstraZeneca Pharma India Limited was 186 347 000 Rs in last quartal, net income changes to -13.389%.
AstraZeneca Pharma India Limited stocks data
ASTRAZEN.BO stock price
AstraZeneca Pharma India Limited stock price today, ASTRAZEN.BO stock quote.
